Surgery in current therapy for infective endocarditis

Vascular Health and Risk Management

Volumn 7, Issue 1, 2011, Pages 255-263

  Head, Stuart J ^a   Mostafa Mokhles, M ^a   Osnabrugge, Ruben L J ^a   Bogers, Ad J J C ^a   Pieter Kappetein, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotics; Complications; Endocarditis; Meta analysis; Mortality; Propensity analysis; Review; Surgery

Indexed keywords

ENDOCARDITIS; HEART SURGERY; HUMAN; METHODOLOGY; REVIEW; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; ENDOCARDITIS; HUMANS; TREATMENT OUTCOME;

EID: 80053297875     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S19377     Document Type: Review

References (86)

1. Cabell CH, Abrutyn E. Progress towards a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am. 2002;16(2): 255-272.
2. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007; 116(5):1736-1754.
3. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. Circulation. 2008;118(15):e523-e661.
4. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96(3):200-209.
5. Heiro M, Helenius H, Mäkilä S, et al. Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart. 2006;92(10):1457-1462.
6. Durante-Mangoni E, Bradley S, Selton-Suty C, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168(19):2095-2103.
7. Mansur AJ, Dal Bó CM, Fukushima JT, Issa VS, Grinberg M, Pomerantzeff PM. Relapses, recurrences, valve replacements, and mortality during the longterm follow-up after infective endocarditis. Am Heart J. 2001;141(1):78-86.
8. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy alone. Ann Thorac Surg. 1994;58(4):1073-1077.
9. Cabell CH, Abrutyn E, Fowler VG Jr, et al. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J.2005;150(5):1092-1098.
10. Aksoy O, Sexton DJ, Wang A, et al. Early Surgery in Patients with Infective Endocarditis: A Propensity Score Analysis. Clin Infect Dis. 2007;44(3):364-372.
11. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115(13):1721-1728.
12. Sy RW, Bannon PG, Bayfield MS, Brown C, Kritharides L. Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes. 2009;2(5): 469-474.
13. Lalani T, Cabell CH, Benjamin DK, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121(8): 1005-1013.
14. Wang A, Pappas P, Anstrom KJ, et al. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J. 2005;150(5): 1086-1091.
15. Bogers AJ, van Vreeswijk H, Verbaan CJ, et al. Early surgery for active infective endocarditis improves early and late results. Thorac Cardiovasc Surg. 1991;39(5):284-288.
16. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influence mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2009; doi:10.1093/ eurheartj/ehp089.
17. San Román JA, López J, Revilla A, et al. Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): a multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditis. Am Heart J. 2008;156(3): 431-436.
18. Tornos MP, Olona M, Permanyer-Miralda G, Almirante B, Evangelista A, Soler-Soler J. Is the clinical spectrum and prognosis of native valve infective endocarditis in non-addicts changing? Eur Heart J. 1995; 16(11):1686-1691.
19. Schulz R, Werner GS, Fuchs JB, et al. Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990's. Eur Heart J. 1996;17(2):281-288.
20. Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22(2):276-286.
21. Olaison L, Hogevik H, Myken P, Oden A, Alestig K. Early surgery in infective endocarditis. QJM. 1996;89(4):267-278.
22. Tornos P, Almirante B, Olona M, et al. Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis. 1997;24(3):381-386.
23. Hricak V, Kovacik J, Marx P, et al. Etiology and risk factors of 180 cases of native valve endocarditis. Report from a 5-year national prospective survey in Slovak Republic. Diagn Microbiol Infect Dis. 1998;31(3): 431-435.
24. Castillo JC, Anguita MP, Ramírez A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart. 2000;83(5):525-530.
25. Gordon SM, Serkey JM, Longworth DL, Lytle BW, Cosgrove DM 3rd. Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997. Ann Thorac Surg. 2000;69(5):1388-1392.
26. Bishara J, Leibovici L, Gartman-Israel D, et al. Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin Infect Dis. 2001;33(10):1636-1643.
27. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88(1):53-60.
28. Mouly S, Ruimy R, Launay R, et al. The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect. 2002;45(4): 246-256.
29. Hoen B, Alla F, Selton-Suty C, et al. Changing Profile of Infective Endocarditis: Results of a 1-Year Survey in France. JAMA. 2002;288(1): 75-81.
30. Pachirat O, Chetchotisakd P, Klungboonkrong V, Taweesangsuksakul P, Tantisirin C, Loapiboon M. Infective endocarditis: prevalence, characteristics and mortality in Khon Kaen, 1990-1999. J Med Adoc Thai. 2002;85(1):1-10.
31. Di Salvo G, Thuny F, Rosenberg V, et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J. 2003;24(17):1576-1583.
32. Ako J, Ikari Y, Hatori M, Hara K, Ouchi Y. Changing spectrum of infective endocarditis: review of 194 episodes over 20 years. Circ J. 2003;67(1):3-7.
33. Akowuah EF, Davies W, Oliver S, et al. Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart. 2003;89(3):269-272.
34. Krcmery V, Gogová M, Ondrusová A, et al. Etiology and risk factors of 339 cases of infective endocarditis: report from a 10-year national prospective survey in the SLovak Republic. J Chemother. 2003; 15(6):579-583.
35. Mourvillier B, Trouillet JL, Timsit JF, et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med. 2004;30(11): 2046-2052.
36. Zamorano J, de Isla LP, Moura L, et al. Impact of echocardiography in the short-and long-term prognosis of patients with infective endocarditis and negative blood cultures. J Heart Valve Dis. 2004;13(6): 997-1004.
37. Cecchi E, Forno D, Imazio M, et al. New trends in the epidemiological and clinical features of infective endocarditis: results of a multicenter prospective study. Ital Heart J. 2004;5(4):249-256.
38. Habib G, Tribouilloy C, Thuny F, et al. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart. 2005; 91(7):954-959.
39. Garg N, Kandpal B, Garg N, et al. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992-2001. Int J Cardiol. 2005;98(2):253-260.
40. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91(5): 571-575.
41. Ferreiros E, Nacinovich F, Casabé JH, et al. Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la República Argentina-2 (EIRA-2) Study. Am Heart J. 2006;151(2):545-552.
42. Leblebicioglu H, Yilmaz H, Tasova Y, et al. Characteristics and analysis of risk factors for mortality in infective endocarditis. Eur J Epidemiol. 2006;21(1):25-31.
43. Abramczuk E, Hryniewiecki T, Stepińska J. Influence of pathogenetic factors on prognosis in patients with native valve infective endocarditis. Kardiol Pol. 2006;64(7):675-681.
44. Slater MS, Komanapalli CB, Tripathy U, Ravichandran PS, Ungerleider RM. Treatment of endocarditis: a decade of experience. Ann Thorac Surg. 2007;83(6):2074-2079.
45. Delahaye F, Alla F, Béguinot I, et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis. 2007;39(10):849-857.
46. Heiro M, Helenius H, Hurme S, et al. Short-term and one-year outcome of infective endocarditis in adult patients treated in a Finnish teaching hospital during 1980-2004. BMC Infect Dis. 2007;7:78.
47. Krecki R, Drozdz J, Ibata G, et al. Clinical profile, prognosis and treatment of patients with infective endocarditis; a 14-year follow-up study. Pol Arch Med Wewn. 2007;117(11-12):512-520.
48. Trabelsi I, Rekik S, Znazen A, et al. Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102(9):1247-1251.
49. Pazdernik M, Baddour LM, Pelouch R. Infective endocarditis in the Czech Republic: eight years of experience at one of the country's largest medical centers. J Heart Valve Dis. 2009;18(4):395-400.
50. Nunes MC, Gelape CL, Ferrari TC. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis. 2010;14(5): e394-e398.
51. Alonso-Valle H, Fariñas-Alvarez C, García-Palomo JD, et al. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg. 2010;139(4): 887-893.
52. López J, Revilla A, Vilacosta I, et al. Age-dependent profile of leftsided infective endocarditis: a 3-center experience. Circulation. 2010; 121(7):892-897.
53. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-473.
54. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003;290(24):3207-3214.
55. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, et al. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol. 2010;63(2):130-135.
56. Kanafani ZA, Kanj SS, Cabell CH, et al. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. Eur J Clin Microbiol Infect Dis. 2010;29(10):1203-1210.
57. Tleyjeh IM, Kashour T, Zimmerman V, Steckelberg JM, Wilson WR, Baddour LM. The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J. 2008;156(5): 901-909.
58. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369-2413.
59. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e395-e434.
60. Revilla A, López J, Villacosta I, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J. 2007;28(1):65-71.
61. Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121(9):1141-1152.
62. Klieverik LM, Yacoub MH, Edwards S, et al. Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses. Ann Thorac Surg. 2009;88(6):1814-1821.
63. Anguera I, Miro JM, Vilacosta I, et al. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J. 2005; 26(3):288-297.
64. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter. Circulation. 2005;112(1):69-75.
65. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis: a 17 year experience in a teaching hospital in Finland. Arch Intern Med. 2000;160(18):2781-2787.
66. Derex L, Bonnefoy E, Delahaye F. Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol. 2010;257:315-321.
67. Remadi JP, Habib G, Nadji G, et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg. 2007;83(4):1295-1302.
68. Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147(12):829-835.
69. Raoult D, Marrie T. Q Fever. Clin Infect Dis. 1995;20(3):489-495.
70. Jacobs F, Abramowicz D, Vereerstraeten P, Le Clerc JL, Zech F, Thys JP. Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis. 1990;12(5):740-744.
71. Anguera I, Del Río A, Miró JM, et al. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart. 2005;91(2):e10.
72. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12): 1354-1361.
73. Hill EE, Herregods MC, Vanderschueren S, Claus P, Peetermans WE, Herijgers P. Management of prosthetic valve infective endocarditis. Am J Cardiol. 2008;101(8):1174-1178.
74. Lytle BW, Priest BP, Taylor PC, et al. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1996;111(1):198-207.
75. Pansini S, di Summa M, Patane F, Forsenatti PG, Serra M, Del Ponte S. Risk of recurrence after reoperation for prosthetic valve endocarditis. J Heart Valve Dis. 1997;6(1):84-87.
76. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345(18):1318-1330.
77. Mokhles MM, Ciampichetti I, Head SJ, Takkenberg JJM, Bogers AJJC. Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg. 2011; doi:10.1016/j. athoracsur. 2011.02.007.
78. Nishida K, Fukuyama O, Nakamura DS. Pulmonary valve endocarditis caused by right ventricular outflow obstruction in association with sinus of valsalva aneurysm: a case report. J Cardiothorac Surg. 2008;3:46.
79. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med. 1992;117(7): 560-566.
80. Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R, et al. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardiothor Surg. 2007;32:118-125.
81. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device related infections. Circulation. 2003;108(16):2015-2031.
82. Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141(1):98-106.
83. Piazza N, Marra S, Webb J, et al. Two cases of aneurysm of the anterior mitral valve leaflet associated with transcatheter aortic valve endocarditis: a mere coincidence? J Thorac Cardiovasc Surg. 2010; 140(3):e36-e38.
84. Head SJ, Dewey TM, Mack MJ. Fungal endocarditis after transfemoral aortic valve implantation. Catheter Cardiovasc Interv. 2011; doi: 10.1002/ccd.23038.
85. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
86. Head SJ, Kappetein AP. Transcatheter aortic valve implantation after PARTNER: what is up next? Euro Intervention. 2010;6(5):560-561.